BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 21116502)

  • 1. Comparative enzyme immunoassay of matrix metalloproteinases-2, -7, -9 and their tissue inhibitor-2 in tumors and plasma of patients with gastric cancer.
    Gerstein ES; Sini L; Ryabov AB; Dvorova EK; Yurchenko AA; Stilidi IS; Kushlinskii NE; Davydov MI
    Bull Exp Biol Med; 2009 Dec; 148(6):899-902. PubMed ID: 21116502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Significance of Matrix Metalloproteinases in Blood Plasma of Patients with Gastric Cancer.
    Kushlinskii NE; Gershtein ES; Ivannikov AA; Davydov MM; Chang VL; Ognerubov NA; Stilidi IS
    Bull Exp Biol Med; 2019 Jan; 166(3):373-376. PubMed ID: 30627896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinases 2, 7, and 9 in tumors and sera of patients with breast cancer.
    Katunina AI; Gershtein ES; Ermilova VD; Tereshkina IV; Nazarenko AY; Tyleuova AA; Dvorova EK; Karabekova ZK; Gritskevich MV; Berezov TT
    Bull Exp Biol Med; 2011 Jul; 151(3):359-62. PubMed ID: 22451887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix metalloproteinases 2, 7, 9 and tissue inhibitor of matrix metalloproteinase-1 in the sera of patients with bone tumors.
    Kushlinsky NE; Solovyov YN; Babkina IV; Gershtein ES; Bulicheva IV
    Bull Exp Biol Med; 2010 Aug; 149(2):233-5. PubMed ID: 21113498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced cell surface expression of matrix metalloproteinases and their inhibitors, and tumor-induced host response in progression of human gastric carcinoma.
    Koyama S
    Dig Dis Sci; 2004 Oct; 49(10):1621-30. PubMed ID: 15573916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix Metalloproteinases and Their Tissue Inhibitors in Blood Serum of Patients with Endometrial Cancer: Clinical and Morphological Correlations.
    Gershtein ES; Mushtenko SV; Ermilova VD; Levchenko NE; Kushlinskii NE
    Bull Exp Biol Med; 2018 May; 165(1):75-79. PubMed ID: 29796809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix-metalloproteinases and their inhibitors in plasma and tumor tissue of patients with renal cell carcinoma.
    Lein M; Jung K; Laube C; Hübner T; Winkelmann B; Stephan C; Hauptmann S; Rudolph B; Schnorr D; Loening SA
    Int J Cancer; 2000 Mar; 85(6):801-4. PubMed ID: 10709099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of serum levels of matrix metalloproteinase 2 (MMP-2) and its tissue inhibitor (TIMP-2) in gastric cancer.
    Mroczko B; Lukaszewicz-Zając M; Gryko M; Kędra B; Szmitkowski M
    Folia Histochem Cytobiol; 2011; 49(1):125-31. PubMed ID: 21526499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in sera and tissue of patients with Dupuytren's disease.
    Ulrich D; Hrynyschyn K; Pallua N
    Plast Reconstr Surg; 2003 Oct; 112(5):1279-86. PubMed ID: 14504511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum matrix metalloproteinases -2, -9 and tissue inhibitors of metalloproteinases -1, -2 in lung cancer--TIMP-1 as a prognostic marker.
    Ylisirniö S; Höyhtyä M; Turpeenniemi-Hujanen T
    Anticancer Res; 2000; 20(2B):1311-6. PubMed ID: 10810441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of vascular-endothelial growth factor, matrix metalloproteinases and tissue inhibitors of metalloproteinases in primary breast cancer.
    Jobim FC; Xavier NL; Uchoa DM; Cruz DB; Saciloto M; Chemello N; Schwartsmann G
    Braz J Med Biol Res; 2009 Oct; 42(10):979-87. PubMed ID: 19787153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinase 2 (MMP-2) and their tissue inhibitor 2 (TIMP-2) in gastric cancer patients.
    Łukaszewicz-Zając M; Mroczko B; Guzińska-Ustymowicz K; Pryczynicz A; Gryko M; Kemona A; Kędra B; Szmitkowski M
    Adv Med Sci; 2013; 58(2):235-43. PubMed ID: 24384769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endometrial tumor invasiveness is related to metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 expressions.
    Graesslin O; Cortez A; Uzan C; Birembaut P; Quereux C; Daraï E
    Int J Gynecol Cancer; 2006; 16(5):1911-7. PubMed ID: 17009991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinases 7 and 9 and their types 1 and 4 tissue inhibitors in tumors and plasma of patients with colorectal cancer.
    Gershtein ES; Korotkova EA; Shcherbakov AM; Prorokov VV; Golovkov DA; Kushlinskii NE
    Bull Exp Biol Med; 2007 Apr; 143(4):459-62. PubMed ID: 18214300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological significance of MMP-2 and its specific inhibitor TIMP-2 in gastric cancer.
    Alakus H; Grass G; Hennecken JK; Bollschweiler E; Schulte C; Drebber U; Baldus SE; Metzger R; Hölscher AH; Mönig SP
    Histol Histopathol; 2008 Aug; 23(8):917-23. PubMed ID: 18498066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and localization of matrix metalloproteinases (MMP-2, -7, -9) and their tissue inhibitors (TIMP-2, -3) in the chicken oviduct during pause in laying induced by tamoxifen.
    Leśniak-Walentyn A; Hrabia A
    Theriogenology; 2017 Jan; 88():50-60. PubMed ID: 27865412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MMP-2 and MMP-9 as prognostic markers for the early detection of urinary bladder cancer.
    Fouad H; Salem H; Ellakwa DE; Abdel-Hamid M
    J Biochem Mol Toxicol; 2019 Apr; 33(4):e22275. PubMed ID: 30548095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activities of matrix metalloproteinases and tissue inhibitor of metalloproteinase-2 in idiopathic hemotympanum and otitis media with effusion.
    Moon SK; Linthicum FH; Yang HD; Lee SJ; Park K
    Acta Otolaryngol; 2008 Feb; 128(2):144-50. PubMed ID: 17851959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imbalance between expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in invasiveness and metastasis of human gastric carcinoma.
    Zhang S; Li L; Lin JY; Lin H
    World J Gastroenterol; 2003 May; 9(5):899-904. PubMed ID: 12717827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limited value of preoperative serum analyses of matrix metalloproteinases (MMP-2, MMP-9) and tissue inhibitors of matrix metalloproteinases (TIMP-1, TIMP-2) in colorectal cancer.
    Oberg A; Höyhtyä M; Tavelin B; Stenling R; Lindmark G
    Anticancer Res; 2000; 20(2B):1085-91. PubMed ID: 10810401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.